THIRD ROCK VENTURES LP
Insider CIK 1408591 · BLUE 10% owner · ZFGN 10% owner · CNST 10% owner · AGIO 10% owner · EBIO 10% owner · FMI 10% owner · CTMX 10% owner · RYTM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, IN | J Other | 2018-08-30 | 2018-09-04 | 1,000,000 | — | $0 | 2,981,437 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | X Exercise deriv | 2018-08-22 | 2018-08-24 | 51,032 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | X Exercise | 2018-08-22 | 2018-08-24 | 51,032 | $1.55 | $79.1K | 3,034,083 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 11,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 10,650,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 1,086,411 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 2,285,640 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-24 | 3,107,930 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-24 | 266,667 | $15.00 | $4.00M | 2,983,051 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-24 | 2,705,334 | — | $0 | 2,716,384 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-10-18 | 2017-10-19 | 1,000,000 | — | $0 | 3,320,348 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-11 | 9,479,502 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-11 | 26,868,642 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-11 | 3,963,810 | — | $0 | 3,981,437 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-07-13 | 2017-07-13 | 850,000 | — | $0 | 4,320,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-27 | 2017-03-27 | 650,000 | $18.00 | $11.70M | 5,170,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-23 | 2017-03-27 | 1,000,000 | $17.00 | $17.00M | 5,820,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2017-03-15 | 2017-03-16 | 850,000 | — | $0 | 6,820,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | J Other | 2016-11-07 | 2016-11-09 | 1,000,000 | — | $0 | 7,670,348 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-23 | 565,037 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-23 | 8,105,314 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-23 | 8,670,351 | — | $0 | 8,670,351 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 479,081 | — | $0 | 479,081 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 1,200,000 | — | $0 | 2,002,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-07-23 | 2015-07-24 | 479,081 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 1,000,000 | — | $0 | 3,202,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 443,935 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-05-15 | 2015-05-18 | 443,935 | — | $0 | 443,935 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 312,498 | — | $0 | 312,498 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 312,498 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 828,456 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-04-07 | 2015-04-09 | 3,976,278 | $50.00 | $198.81M | 950,956 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-04-07 | 2015-04-16 | 4,098,778 | $50.00 | $204.94M | 828,456 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 346,658 | — | $0 | 346,658 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 346,658 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | J Other | 2015-03-24 | 2015-03-25 | 1,400,000 | — | $0 | 4,202,045 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2015-02-19 | 2015-02-19 | 760,195 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2015-02-19 | 2015-02-19 | 760,195 | — | $0 | 760,195 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2015-02-19 | 2015-02-19 | 3,070,090 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-02-03 | 2015-02-04 | 1,215,054 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-02-03 | 2015-02-04 | 300,863 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-02-03 | 2015-02-04 | 300,863 | — | $0 | 300,863 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-09-12 | 2014-09-12 | 38,000 | $36.59 | $1.39M | 1,215,054 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-09-11 | 2014-09-12 | 87,000 | $36.52 | $3.18M | 2,329,974 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-09-11 | 2014-09-12 | 79,062 | — | $0 | 79,062 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-09-11 | 2014-09-12 | 79,062 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-09-11 | 2014-09-12 | 1,076,920 | — | $0 | 1,253,054 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-09-11 | 2014-09-12 | 60,567 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-09-11 | 2014-09-12 | 825,000 | — | $0 | 3,070,090 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-09-11 | 2014-09-12 | 60,567 | — | $0 | 60,567 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 22,250,770 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 8,263,595 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion deriv | 2014-06-24 | 2014-06-26 | 4,666,478 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-24 | 2014-06-25 | 1,669,324 | — | $0 | 3,895,090 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-24 | 2014-06-25 | 122,554 | — | $0 | 122,554 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | J Other | 2014-06-24 | 2014-06-25 | 122,554 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 1,315,859 | — | $0 | 4,858,975 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 743,070 | — | $0 | 5,602,045 | SEC↗ |
| ZFGN ZAFGEN, INC. | C Conversion | 2014-06-24 | 2014-06-26 | 3,543,116 | — | $0 | 3,543,116 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 1,642,411 | — | $0 | 4,927,234 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 120,577 | — | $0 | 120,577 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-12 | 120,577 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 127,077 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 20,750,000 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 3,058,281 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion deriv | 2014-02-11 | 2014-02-13 | 82,989 | — | $0 | 0 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 481,619 | — | $0 | 4,080,043 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | P Buy | 2014-02-11 | 2014-02-13 | 551,482 | — | $0 | 4,841,591 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 127,077 | $0.06 | $7.6K | 4,207,120 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 82,989 | — | $0 | 4,290,109 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | C Conversion | 2014-02-11 | 2014-02-13 | 3,267,716 | — | $0 | 3,598,424 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-21 | 2014-01-23 | 250,000 | $23.91 | $5.98M | 2,416,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-17 | 2014-01-17 | 14,000 | $23.96 | $335.4K | 2,666,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-16 | 2014-01-17 | 33,000 | $24.02 | $792.7K | 2,680,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-15 | 2014-01-17 | 260,000 | $22.14 | $5.76M | 2,713,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-14 | 2014-01-14 | 270,000 | $21.91 | $5.92M | 2,973,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-13 | 2014-01-14 | 45,000 | $21.80 | $981.0K | 3,243,974 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-01-10 | 2014-01-14 | 25,000 | $21.98 | $549.5K | 3,288,974 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2013-12-16 | 2013-12-18 | 104,271 | — | $0 | 104,271 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2013-12-16 | 2013-12-18 | 1,420,274 | — | $0 | 3,313,974 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2013-12-16 | 2013-12-18 | 104,271 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 1,106,194 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 23,772,388 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 5,943,097 | — | $0 | 6,293,097 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 276,548 | — | $0 | 6,569,645 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 802,141 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion deriv | 2013-07-29 | 2013-07-31 | 13,000,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | C Conversion | 2013-07-29 | 2013-07-31 | 5,018,960 | — | $0 | 5,564,414 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 11,037,527 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 64,377,682 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 14,379,294 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion | 2013-06-24 | 2013-06-26 | 4,734,248 | — | $0 | 4,734,248 | SEC↗ |